Advertisement
Screener

BRIACELL THERAPEUTICS CORP. (BCTX) Assets

2.8 / 5 stars · 68/120 Roast Me

BRIACELL THERAPEUTICS CORP. Assets

BRIACELL THERAPEUTICS CORP. (BCTX) had Assets of $46.46 million as of 2022-04-30, per its 6-K filed 2022-06-13.

Discontinued › Notes

ifrs-full:Assets · last filed 2022-06-13

  • 2020-07-31: Assets 641.68K CAD.
  • 2019-08-01: Assets 546.26K CAD.

CAD

Period endAssets
2020-07-31641.68K CAD
40-F/A · filed 2021-11-16
2019-08-01546.26K CAD
40-F/A · filed 2021-11-16

USD

Period endAssets
2022-04-30$46.46M
6-K · filed 2022-06-13
2022-01-31$48.55M
6-K · filed 2022-03-15
2021-07-31$58.04M
6-K · filed 2022-06-13
2020-07-31$522.33K
40-F/A · filed 2021-11-16
2019-08-01$444.66K
40-F/A · filed 2021-11-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
PMGC Holdings Inc. (ELAB)United States$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
Edesa Biotech, Inc. (EDSA)Canada$0.039B
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98